Hot Stocks Watch: ADVENTRX Pharmaceuticals — Sickle Cell Anemia, Endothelial Dysfunction

ADVENTRX (NYSE: ANX), a San Diego-based biopharmaceutical company, has made some strides in the development of a product candidate designed to treat genetic hematoma disorders, specifically sickle cell anemia (SCA), an orphan drug market with implications for millions of people.

Read more »